Skip to main content
OpenTrials

Clinical trial condition

RSV Infection

Explore clinical trials studying RSV Infection. Study availability and eligibility vary by location and protocol.

52 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

RSV Infection trial results

Completed

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

NCT05268939

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Diagnamics, Inc Encinitas, California, United States
  • Marisela Gonzalez, MD, PA Miami, Florida, United States
  • Excellence Medical and Research Miami Gardens, Florida, United States
View Trial Details
Completed

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

NCT04782336

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +19 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Lothian - Royal Hospital for Children & Young People Edinburgh, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • Barts Health NHS Trust London, United Kingdom
View Trial Details
Completed

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

NCT04938830

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Miller Children's & Women's Hospital Long Beach ( Site 0001) Long Beach, California, United States
  • Children's Hospital of Orange County ( Site 0047) Orange, California, United States
  • Children's Hospital Colorado ( Site 0011) Aurora, Colorado, United States
  • Children's National Medical Center ( Site 0020) Washington D.C., District of Columbia, United States
View all 146 locations
View Trial Details
Completed

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

NCT06583031

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +6 more
Locations
  • Site # 0361004 Botany, New South Wales, Australia
  • Site # 031001 Brookvale, New South Wales, Australia
  • Site # 0361006 Miranda, New South Wales, Australia
  • Site # 0361002 Wollongong, New South Wales, Australia
View Trial Details

Related conditions